Publication Topic

Xue Y, Wang L, Huo R, Chen M, Melo B, Dingley K, et al. 2024. 1β-Hydroxydeoxycholic acid as an endogenous biomarker in human plasma for assessment of CYP3A clinical drug-drug interaction potential. Drug Metab Dispos 52(9):966–974; doi: 10.1124/dmd.124.001680. PMID: 38991779.

Williams Z, Covell L, Tung P, Bloomquist TR, Schilling K, Deyssenroth M, et al. Investigating the influence of prenatal metals exposures on childhood mitochondrial biomarkers. Poster presentation P532 at Society of Toxicology 63rd Annual Meeting, Salt Lake City, UT, March 2024. In: The Toxicologist 198(S1):223, Abstract 3389.

Pouillot R, Farakos SS, Spungen J, Schaefer HR, Flannery BM, Van Doren JM. 2022. Cadmium physiologically based pharmacokinetic (PBPK) models for forward and reverse dosimetry: Review, evaluation, and adaptation to the U.S. population. Toxicol Lett 367(Aug):67-75; doi: 10.1016/j.toxlet.2022.07.812. PMID: 35901988. Corrigendum: Toxicol Lett 2023 377(March):14-15; doi: 10.1016/j.toxlet.2023.01.011.

Verwiel A, Racz L, Mittal L, Rish W. 2022. CDC’s national report on human exposure to environmental chemicals. SETAC Globe, June 1, 2022.

Mease K, Kimzey A, Lansita J. 2017. Biomarkers for nonclinical infusion reactions in marketed biotherapeutics and considerations for study design. Curr Opin Toxicol 4(June):1–15; doi: 10.1016/j.cotox.2017.03.005.

Goodsaid FM, Amur S, Aubrecht J, Burczynski ME, Catalano J, Carl K, Charlab C,…Robison TW, et al. 2010. Experience and impact of the US FDA and EMEA Voluntary Data Submissions (VXDS). Nat Rev Drug Discover 9:435-45; doi: 10.1038/nrd3116.

Morimoto L, Kelsh MA. 2007. Biomarkers. In: Boslaugh S (ed.), Encyclopedia of Epidemiology. Sage Publications.

Stokes WS, Chambers W, Bonner M, Allen DG, Tice RR, Choksi NY, et al. In vivo models of ocular injury and recovery: Current and potential biomarkers to support development and validation of predictive in vitro models. Presented at the 5th World Congress on Alternatives and Animal Use in the Life Sciences, Berlin, Germany, August 2005.

Eskes C, Allen DG, Tice RR, Choksi NY, Truax JF, Chambers W, Stokes WS, Schechtman LM. In vitro models for ocular injury: Current and potential biomarkers. Presented at the 5th World Congress on Alternatives and Animal Use in the Life Sciences, Berlin, Germany, August 2005.

Monticello TM, Barton D, Ma X, Babish JG, Durham SK. 1995. Comparison of acute hepatocellular proliferating cell nuclear antigen (PCNA) labeling indices and growth fractions, p34^cdc2 kinases, and serum enzymes in carbon tetrachloride-treated rats. Toxicol Pathol 23(4):439-446; doi: 10.1177/019262339502300401.